TEV-48574 Dose Regiment B ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	1

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05668013 (ClinicalTrials.gov)	January 11, 2023	12/12/2022	A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Cr ...	A 24-Week Phase 2b Long-Term Extension, RandomizEd, Double-BLind, Study to Determine the Long-Term P ...	Crohn Disease;Colitis, Ulcerative	Drug: TEV-48574 Dose Regimen A;Drug: TEV-48574 Dose Regiment B	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Recruiting	18 Years	75 Years	All	128	Phase 2	United States

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05668013 (ClinicalTrials.gov)	January 11, 2023	12/12/2022	A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Cr ...	A 24-Week Phase 2b Long-Term Extension, RandomizEd, Double-BLind, Study to Determine the Long-Term P ...	Crohn Disease;Colitis, Ulcerative	Drug: TEV-48574 Dose Regimen A;Drug: TEV-48574 Dose Regiment B	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Recruiting	18 Years	75 Years	All	128	Phase 2	United States